Table 2.
Displacement of [64Cu]Cu-ATSM and [64Cu]Cu-ETS from HSA by Drug Competition
| % Free (corrected) ± SD (n ≥ 3) | ||||
|---|---|---|---|---|
| [64Cu]Cu-ATSM | [64Cu]Cu-ETS | |||
| Mole Ratio (Drug:HSA) |
Warfarin | Ibuprofen | Warfarin | Ibuprofen |
| 0 | 5.9 ± 0.4 | 5.9 ± 0.4 | 40.6 ± 1.1 | 40.6 ± 1.1 |
| 0.5 | 7.3 ± 0.2 | 7.1 ± 0.6 | 42.8 ± 1.6 | 43.9 ± 2.2 |
| 1 | 9.4 ± 0.8 | 7.5 ± 0.8 | 44.2 ± 1.2 | 42.1 ± 2.7 |
| 2 | 12.4 ± 0.9 | 8.2 ± 1.1 | 45.2 ± 1.3 | 45.8 ± 2.6 |
| 4 | 14.5 ± 0.6 | 7.3 ± 0.8 | 42.8 ± 3.4 | 43.6 ± 3.1 |
| 8 | 19.0 ± 1.7 | 10.5 ± 1.1 | 44.7 ± 2.7 | 49.6 ± 1.2 |